Initial Management of Syncope

Initial Assessment Components

• The American College of Cardiology and the American Heart Association recommend that the initial evaluation of a patient presenting with syncope should include a careful history, physical examination including orthostatic blood pressure measurements, and a 12-lead electrocardiogram (ECG) 1, 2
• The European Heart Journal suggests focusing on circumstances before the attack, including position, activity, predisposing factors, and precipitating events, when taking a patient's history 3
• A complete cardiovascular examination with attention to heart rate, rhythm, murmurs, gallops, or rubs that may indicate structural heart disease is recommended by the American College of Cardiology 2, 4
• Orthostatic blood pressure measurements in lying, sitting, and standing positions are recommended by the American College of Cardiology 2, 4

Risk Stratification

• The American College of Cardiology recommends considering older age (>60 years), male sex, known heart disease, brief or absent prodrome, syncope during exertion or in supine position, low number of episodes (1-2), abnormal cardiac examination, and family history of inheritable conditions or premature sudden cardiac death as high-risk features for cardiac causes of syncope 1, 2
• The American College of Cardiology also recommends considering younger age, no known cardiac disease, syncope only when standing, positional change triggers, prodromal symptoms, specific triggers, and situational triggers as low-risk features for non-cardiac causes of syncope 1, 2

Disposition Decision

• The American College of Cardiology recommends hospital admission for patients with serious medical conditions identified during initial evaluation, suspected cardiac syncope with abnormal ECG, structural heart disease, or concerning history, and high-risk features suggesting increased morbidity and mortality 1, 2
• Outpatient management is appropriate for presumptive reflex-mediated (neurally mediated) syncope without serious medical conditions, according to the American College of Cardiology 1, 2

Additional Testing Based on Initial Evaluation

• The American College of Cardiology recommends transthoracic echocardiography when structural heart disease is suspected, exercise stress testing for syncope during exertion, and cardiac monitoring (selection based on frequency and nature of events) 1, 2
• Targeted blood tests based on clinical assessment, rather than routine comprehensive testing, are recommended by the American College of Cardiology 5

Common Pitfalls to Avoid

• The European Heart Journal warns against failing to distinguish syncope from non-syncopal causes of transient loss of consciousness 3
• The American College of Cardiology advises against performing comprehensive laboratory testing without clinical indication 5
• The European Heart Journal also recommends avoiding overlooking orthostatic hypotension as a potential cause of syncope 3

Syncope Evaluation and Management

Initial Assessment Components

• The European Society of Cardiology recommends obtaining detailed information about circumstances before the attack, including position, activity, and predisposing factors, to establish diagnosis, determine etiology, and assess risk of adverse outcomes 6, 7
• The European Heart Journal suggests documenting onset symptoms, including presence of prodrome, palpitations before syncope, and assessing recovery phase, to determine the cause of syncope 6, 7
• A complete cardiovascular examination, including orthostatic blood pressure measurements and carotid sinus massage in patients over 40 years, is recommended to assess for structural heart disease 6
• The European Heart Journal recommends a 12-lead ECG in all patients to look for specific ECG abnormalities suggesting arrhythmic syncope, such as bifascicular block, conduction abnormalities, and evidence of ischemia 6, 7

Risk Stratification

• The European Heart Journal suggests that abnormal ECG, history of heart failure or structural heart disease, and low blood pressure (systolic BP <90 mmHg) are high-risk features that warrant hospital admission 6, 8, 9
• The American College of Cardiology recommends considering outpatient management for patients with low-risk features, such as younger age, no known cardiac disease, and normal ECG 6, 9
• The European Heart Journal recommends using the OESIL score (≥2) or EGSYS score (≥3) to stratify patients into high-risk and low-risk categories 6, 8

Additional Testing Based on Initial Evaluation

• The European Heart Journal recommends an echocardiogram when structural heart disease is suspected, or when there are abnormal cardiac examination or ECG findings suggesting structural heart disease 6
• The European Heart Journal suggests cardiac monitoring when arrhythmic syncope is suspected, and orthostatic challenge testing when syncope is related to standing position or orthostatic hypotension is suspected 6
• The American College of Cardiology recommends targeted blood tests based on clinical assessment, such as complete blood count, electrolytes, and glucose, to rule out underlying conditions that may be contributing to syncope 9

Laboratory Testing for Syncope Evaluation

Initial Approach to Laboratory Testing

• The American College of Cardiology recommends that targeted blood tests are reasonable in the evaluation of selected patients with syncope based on clinical assessment from history, physical examination, and ECG, but routine comprehensive laboratory testing is not useful 10
• Basic laboratory tests are only indicated if syncope may be due to loss of circulating volume or if a syncope-like disorder with a metabolic cause is suspected, as suggested by the European Heart Journal 11
• Routine and comprehensive laboratory testing has been shown to be not useful in the evaluation of patients with syncope, according to the American College of Cardiology 10, 12

Recommended Laboratory Tests Based on Clinical Suspicion

Volume Depletion/Blood Loss

• Hematocrit is included in the San Francisco Syncope Rule as a risk factor when <30%, as reported by the European Heart Journal 13, 14

Metabolic Disorders

• Renal function tests, such as BUN and creatinine, should be considered when dehydration is suspected, as recommended by the American College of Cardiology 10

Cardiac Causes

• Brain natriuretic peptide (BNP) and high-sensitivity troponin may be considered when cardiac cause is suspected, though their usefulness is uncertain, according to the American College of Cardiology 10, 12
• These cardiac biomarkers should not be routinely ordered for all syncope patients, as stated by the American College of Cardiology 10

Risk Stratification and Laboratory Testing

• Laboratory testing should be more comprehensive in high-risk patients, including those with abnormal ECG, history of cardiovascular disease, age >65 years, syncope during effort, and absence of prodromal symptoms, as suggested by the European Heart Journal 14, 15

Algorithm for Laboratory Testing in Syncope

• The initial evaluation should include history, physical exam, and ECG, as recommended by the European Heart Journal 16, 13
• If syncope is likely due to volume depletion or metabolic cause, targeted tests such as CBC/hematocrit and electrolytes should be ordered, as suggested by the European Heart Journal 11, 13, 14
• If cardiac cause is suspected, consider cardiac biomarkers (BNP, troponin), as recommended by the American College of Cardiology 10
• Comprehensive panels should not be ordered without specific indications, as stated by the American College of Cardiology 10, 12

Common Pitfalls to Avoid

• Ordering comprehensive laboratory panels for all syncope patients without specific indications should be avoided, as recommended by the American College of Cardiology 10, 12
• Laboratory testing should be viewed as supplementary to a thorough history and physical examination, and tests should be ordered based on specific clinical suspicions rather than as a routine panel, as suggested by the American College of Cardiology 10

Diagnostic Approach to Syncope

Initial Evaluation and Testing

• The American Heart Association recommends that brain imaging studies such as MRI and CT are not used in the routine evaluation of patients with syncope in the absence of focal neurological findings or head injury that support further evaluation 17, 18
• A thorough history focusing on circumstances before the attack is the cornerstone of syncope evaluation, according to the European Society of Cardiology 19
• The European Society of Cardiology suggests that a 12-lead ECG should be performed in all patients to identify potential cardiac causes 19

Neurological Testing in Syncope

• Brain imaging (CT/MRI) is not recommended routinely for syncope evaluation, with a diagnostic yield of only 0.24% for MRI and 1% for CT, as stated by the American Heart Association 17, 18
• The American Heart Association indicates that EEG is not recommended routinely for syncope evaluation, with a diagnostic yield of only 0.7% 17, 18
• Carotid artery imaging is not recommended routinely for syncope evaluation, with a diagnostic yield of only 0.5%, according to the American Heart Association 17, 18

Appropriate Diagnostic Testing Based on Initial Evaluation

• The European Society of Cardiology recommends echocardiography when structural heart disease is suspected 19
• The American College of Cardiology suggests that prolonged electrocardiographic monitoring (Holter, event recorder, implantable loop recorder) may be used in the evaluation of syncope 20
• The European Society of Cardiology recommends exercise testing for syncope during or after exertion 21
• The American College of Cardiology indicates that electrophysiological studies may be used in selected cases of syncope evaluation 22
• Tilt-table testing is recommended for suspected vasovagal syncope when initial evaluation is unclear, according to the American College of Cardiology 22

Common Pitfalls to Avoid

• The American Heart Association advises against ordering brain imaging studies (CT/MRI) without specific neurological indications 17, 18
• The American Heart Association recommends against routine EEG testing without specific neurological features suggesting seizure 17, 18

Syncope Evaluation and Management

Initial Assessment

• The European Society of Cardiology recommends focusing on position and activity during the event, predisposing factors, precipitating events, prodromal symptoms, eyewitness account, recovery phase symptoms, and background information during history taking 23, 24
• The European Society of Cardiology suggests considering basic laboratory tests only if indicated by history or exam, such as CBC or electrolytes 23

Risk Stratification

• The European Society of Cardiology identifies high-risk features, including abnormal ECG findings, such as sinus bradycardia, sinoatrial blocks, or 2nd or 3rd degree AV block, which may indicate the need for admission 25
• The European Society of Cardiology recommends considering low-risk features, such as younger age, no known cardiac disease, normal ECG, syncope only when standing, prodromal symptoms, and specific situational triggers, which may indicate outpatient management 25

Directed Testing

• The European Society of Cardiology recommends echocardiography when structural heart disease is suspected, exercise stress testing for syncope during or after exertion, and prolonged ECG monitoring based on frequency of events 23
• The European Society of Cardiology suggests tilt-table testing for recurrent unexplained syncope and carotid sinus massage in patients over 40 years 23, 25

Management of Unexplained Syncope

• The European Society of Cardiology recommends reappraising the entire workup for subtle findings or new information and considering specialty consultation if unexplored clues to cardiac or neurological disease are present 23
• The European Society of Cardiology suggests considering prolonged monitoring with implantable loop recorder for recurrent unexplained syncope 23

Common Pitfalls to Avoid

• The European Society of Cardiology warns against neglecting medication effects as potential contributors to syncope 24

Initial Management of Syncope

Initial Assessment Components

• The European Society of Cardiology recommends obtaining a detailed history focusing on circumstances before the attack, including position, activity, predisposing factors, and precipitating events, as well as documenting symptoms at onset, during, and after the attack 26
• Basic laboratory tests are only indicated if syncope may be due to loss of circulating volume or if a metabolic cause is suspected, according to the European Heart Journal 26

Targeted Diagnostic Testing

• The European Heart Journal recommends echocardiography as a first evaluation step in patients with suspected heart disease 26
• ECG monitoring is recommended in patients with palpitations associated with syncope, as suggested by the European Heart Journal 26
• Stress testing is recommended in patients with chest pain suggestive of ischemia before or after loss of consciousness, according to the European Heart Journal 26
• Tilt testing is recommended in young patients without suspicion of heart or neurological disease and recurrent syncope, as recommended by the European Heart Journal 26
• Carotid sinus massage is recommended as a first evaluation step in older patients, according to the European Heart Journal 26
• Echocardiography and stress testing are recommended in patients with syncope during or after effort, as suggested by the European Heart Journal 26

Management of Unexplained Syncope

• Reappraisal of the work-up is needed if no cause is determined after initial evaluation, including obtaining additional history details, reexamining patients, and reviewing the entire work-up, as recommended by the European Heart Journal 26
• Consultation with appropriate specialty services may be needed if unexplored clues to cardiac or neurological disease are apparent, according to the European Heart Journal 26

Syncope Diagnosis and Management

Initial Evaluation and Diagnostic Approach

• The European Society of Cardiology recommends determining if syncope occurred during exertion, neck turning, or in specific positions 27
• Echocardiography, prolonged electrocardiographic monitoring, and electrophysiological studies are recommended for suspected heart disease 27
• Electrocardiographic monitoring and echocardiography are recommended for palpitations associated with syncope 27
• Stress testing, echocardiography, and electrocardiographic monitoring are recommended for chest pain suggestive of ischemia before/after syncope 27
• Tilt testing is recommended for young patients without heart/neurological disease and recurrent syncope 27
• Carotid sinus massage is recommended for older patients with recurrent syncope 27
• Echocardiography and stress testing are recommended for syncope during/after effort 27
• Specific diagnosis should be made with appropriate neurological testing for signs of autonomic failure or neurological disease 27
• Psychiatric assessment is recommended for frequent recurrent syncope with multiple somatic complaints 27

Specialized Testing and Management

• In-hospital monitoring is warranted only for high-risk patients, and implantable loop recorders should be considered when the mechanism remains unclear after full evaluation 27, 28
• Re-appraisal of the entire work-up and consideration of consultation with appropriate specialty services are recommended for unexplained syncope 27
• Implantable loop recorder is recommended for patients with clinical or ECG features suggesting arrhythmic syncope or history of recurrent syncopes with injury 27

Impact on Quality of Life and Morbidity

• Recurrent syncope is associated with fractures and soft-tissue injury in 12% of patients, and significantly impairs quality of life 29
• There is a significant negative relationship between frequency of syncopal episodes and overall perception of health 29

Evaluation of Syncope

Patient Risk Assessment

• The American College of Cardiology suggests that patients with a history of coronary artery disease and severe ostial left main stenosis are at high risk for cardiac syncope 30
• The American College of Cardiology recommends considering moderate aortic valve stenosis as a high-risk feature for cardiac syncope 30
• Patients with known structural heart disease, such as severe ostial left main stenosis and moderate aortic valve stenosis, are likely to have a cardiac etiology for their syncope 30, 31

Cardiac Monitoring Recommendations

• The American College of Cardiology, American Heart Association, and Heart Rhythm Society guidelines provide a Class IIa recommendation (Level of Evidence: B-NR) for using a Holter monitor in patients with syncope of suspected arrhythmic etiology 30, 32
• The choice of cardiac monitor should be determined by the frequency and nature of syncope events, with a Class I recommendation (Level of Evidence: C-EO) for selecting the appropriate device 33, 34
• For patients with less frequent symptoms, consider using an external loop recorder or implantable cardiac monitor 33, 34

Carotid Ultrasound Not Recommended

• The American Heart Association recommends against routine carotid artery imaging in patients with syncope without focal neurological findings (Class III: No Benefit, Level of Evidence: B-NR) 35, 36
• Carotid ultrasound has a low diagnostic yield in patients with syncope, with only 0.5% of patients having a positive finding 35, 36

Management Algorithm

• Obtain a Holter monitor to evaluate for arrhythmias in patients with syncope, as recommended by the American College of Cardiology 30, 32
• Consider longer-term monitoring with an external loop recorder or implantable cardiac monitor if the Holter monitor is non-diagnostic and symptoms persist 33, 34

Common Pitfalls to Avoid

• Ordering carotid ultrasound for syncope without focal neurological findings is not recommended by guidelines and is a low-yield test 35, 36
• Failing to select the appropriate cardiac monitoring device based on symptom frequency can lead to inadequate evaluation 33
• Not recognizing that syncope in a patient with structural heart disease carries a higher risk of adverse outcomes 30

Differential Diagnosis for Syncope at Rest

Organizing Framework by Mechanism

• The European Society of Cardiology recommends that the differential diagnosis for syncope at rest should be organized by mechanism and risk, with cardiac causes representing the most life-threatening category requiring immediate exclusion 37, 38
• Cardiac syncope, including arrhythmic causes such as bradyarrhythmias and tachyarrhythmias, is a high-risk category that demands immediate attention 37, 38, 39
• The European Heart Journal suggests that structural heart disease, including severe aortic stenosis, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy, should be considered in the differential diagnosis for syncope at rest 37, 38
• Reflex syncope, also known as neurally-mediated syncope, is the most common type of syncope overall, but is less typical at rest, and can be caused by vasovagal syncope or situational syncope 39
• Orthostatic hypotension, defined as a systolic blood pressure drop of ≥20 mmHg or to <90 mmHg upon standing, can also cause syncope at rest, and can be caused by medication-induced, volume depletion, or autonomic failure 39

Critical Teaching Points for Risk Stratification

• Syncope at rest is a high-risk feature that demands cardiac evaluation, and patients with this symptom should be admitted for further evaluation 37, 38
• The presence of abnormal ECG findings, known structural heart disease, or heart failure increases the risk of cardiac syncope and requires urgent evaluation 37, 38
• A family history of sudden cardiac death or inherited cardiac conditions also increases the risk of cardiac syncope and should be considered in the differential diagnosis 37, 38

Essential Initial Evaluation Components

• A detailed history focusing on position during the event, prodromal symptoms, and witness account of the event is essential in evaluating patients with syncope at rest 39
• A physical examination including orthostatic vital signs and carotid sinus massage in patients >40 years can help identify underlying causes of syncope 39
• A 12-lead ECG looking for conduction abnormalities, QT prolongation, or signs of ischemia can help identify cardiac causes of syncope 37, 38, 39

Syncope Evaluation and Management

Initial Evaluation

• The European Society of Cardiology recommends a detailed history, physical examination with orthostatic blood pressure measurements, and a 12-lead ECG for every patient presenting with syncope, as this triad alone establishes the diagnosis in 23-50% of cases 40
• Position during syncope, such as supine or standing, can suggest cardiac or reflex/orthostatic etiology, respectively 40
• Activity before syncope, such as exertional syncope, is high-risk and suggests cardiac etiology 40
• Triggers, such as warm crowded places or prolonged standing, can suggest vasovagal syncope 40
• Presence or absence of warning symptoms, such as nausea or diaphoresis, is critical in distinguishing syncope types 40
• Palpitations before syncope suggest arrhythmic cause 40
• Duration of unconsciousness, skin color, and movements during the event can help distinguish syncope from seizure 40
• Rapid, complete recovery without confusion confirms syncope 40
• Known structural heart disease or heart failure is a significant factor in syncope evaluation 40
• Medications, such as antihypertensives or QT-prolonging agents, can contribute to syncope 40

Risk Stratification

• The European Heart Journal suggests that patients with low number of episodes (1-2 lifetime episodes) are more concerning than those with many episodes 40

Additional Testing

• Echocardiography is mandatory for syncope during or after exertion, and should be ordered when structural heart disease is suspected 40
• Cardiac monitoring, such as Holter or event recorder, should be ordered when arrhythmic syncope is suspected 40
• Exercise stress testing is mandatory for syncope during or immediately after exertion 40
• Tilt-table testing can be considered for recurrent unexplained syncope in young patients without heart disease when reflex mechanism is suspected 40
• Overlooking medication effects, such as antihypertensives or QT-prolonging drugs, as contributors to syncope is a common pitfall 40

Syncope Evaluation and Management

Patient History and Risk Factors

• The American Heart Association recommends assessing adherence patterns in patients with syncope, particularly in those with hearing impairment, to ensure accurate medication use 41
• The European Heart Journal suggests that the presence or absence of warning symptoms, such as nausea or diaphoresis, can help differentiate between vasovagal and arrhythmic causes of syncope 41, 42
• A family history of sudden cardiac death or inherited arrhythmia syndromes is a significant risk factor for cardiac-related syncope, as noted by the American College of Cardiology 41
• The European Heart Journal recommends assessing for prodromal symptoms, such as palpitations, to determine the likelihood of an arrhythmic cause of syncope 43

Physical Examination and Diagnostic Tests

• The American Heart Association recommends performing orthostatic vital sign measurements to assess for orthostatic hypotension, a common cause of syncope 41
• The European Heart Journal suggests that a positive carotid sinus massage test, characterized by asystole >3 seconds or systolic BP drop >50 mmHg, can indicate a cardiac cause of syncope 41
• The Journal of the American College of Cardiology recommends assessing for focal neurological signs, which can indicate a neurological cause of syncope, and performing brain imaging if signs are present 44, 45
• The European Heart Journal recommends interpreting ECG results, including assessing for QT prolongation, conduction abnormalities, and signs of ischemia or prior MI, to determine the underlying cause of syncope 46

Investigation and Management

• The American College of Cardiology recommends continuous cardiac telemetry monitoring for patients with syncope and abnormal ECG findings, such as bradycardia or QT prolongation 46
• The European Heart Journal suggests that repeat electrolyte measurements, including magnesium and phosphate, are necessary to assess for electrolyte abnormalities that may contribute to syncope 46
• The American Heart Association recommends transthoracic echocardiography to assess for structural heart disease in patients with syncope and elevated troponin levels 46
• The Journal of the American College of Cardiology recommends Holter monitoring for patients with suspected arrhythmic syncope, particularly if telemetry is non-diagnostic 43

Syncope Management Guideline

Initial Treatment Strategies

• The European Society of Cardiology recommends reassurance and education as the cornerstone of management for vasovagal syncope patients, given the benign nature of the condition, and suggests trigger avoidance, volume expansion, and medication review as additional measures 47
• The European Heart Journal suggests that physical counterpressure maneuvers, such as leg crossing, arm tensing, and squatting, can reduce syncope risk by ~50% in patients with vasovagal syncope 47
• The guideline recommends against the use of beta-blockers for vasovagal syncope, as five long-term controlled studies have failed to show efficacy 47
• For orthostatic hypotension, non-pharmacological measures such as avoiding rapid position changes, increasing sodium and fluid intake, and physical counterpressure maneuvers are recommended, along with medication review and potential pharmacotherapy with midodrine or fludrocortisone 47

Diagnostic Approach to Syncope

Initial Evaluation

• The European Society of Cardiology recommends verifying the event represents true syncope: transient loss of consciousness with rapid, complete recovery without post-event confusion, to distinguish from seizure, stroke, or metabolic causes 48
• The European Heart Journal suggests that a history of structural heart disease or heart failure has 95% sensitivity for cardiac syncope 48
• The European Heart Journal notes that medications such as antihypertensives, diuretics, vasodilators, and QT-prolonging agents should be reviewed as they are common contributors to syncope 49

Risk Stratification and Management

• The European Heart Journal recommends that high-risk features such as abnormal ECG findings, known structural heart disease or heart failure, syncope during exertion or while supine, and absence of prodromal symptoms require hospital admission for further evaluation 48
• The European Heart Journal suggests that palpitations associated with syncope indicate an arrhythmic cause 49
• The European Heart Journal recommends directed testing based on initial evaluation, including echocardiography, prolonged cardiac monitoring, and electrophysiological study for high-risk patients 48
• The European Heart Journal notes that tilt-table testing can confirm vasovagal syncope when history is suggestive but not diagnostic 49

Syncope Evaluation and Management

Differential Diagnosis

• The European Society of Cardiology recommends organizing the differential diagnosis for syncope into four primary categories: reflex-mediated, cardiac, orthostatic hypotension, and cerebrovascular causes, with cardiac syncope representing the highest-risk category requiring immediate exclusion 50
• Cardiac syncope is associated with a high risk of mortality, with a one-year mortality rate of 20-30% 50
• The American Heart Association suggests that arrhythmic causes, such as bradyarrhythmias and tachyarrhythmias, should be considered in the differential diagnosis of syncope 51, 50
• Structural heart disease, including severe aortic stenosis and hypertrophic cardiomyopathy, is a significant cause of cardiac syncope 50, 52

Reflex-Mediated Syncope

• The European Society of Cardiology notes that vasovagal syncope is the most common type of reflex-mediated syncope, triggered by factors such as prolonged standing, crowded or hot places, and emotional stress 50, 52
• Carotid sinus hypersensitivity is a rare cause of reflex-mediated syncope, triggered by head rotation, pressure on the carotid sinus, or tight collars 50, 52

Orthostatic Hypotension

• The American Autonomic Society recommends considering medication-induced orthostatic hypotension, particularly with antihypertensives, diuretics, and vasodilators, as a potential cause of syncope 51, 52
• Autonomic failure, including primary autonomic failure and diabetic neuropathy, is a significant cause of orthostatic hypotension 50, 52

Initial Evaluation

• A detailed history, including circumstances before the attack, activity, and precipitating factors, is essential in the evaluation of syncope 50, 52
• The European Society of Cardiology recommends performing a physical examination, including orthostatic vital signs, and a 12-lead ECG as part of the initial evaluation 50, 51
• The American Heart Association suggests that any abnormality on the baseline ECG is an independent predictor of cardiac syncope and increased mortality 51, 52

Risk Stratification

• The European Society of Cardiology recommends considering high-risk features, such as age >60 years, known structural heart disease, and abnormal ECG, when determining the need for hospital admission and cardiac evaluation 50, 51
• The American College of Cardiology suggests that patients with high-risk features, such as syncope during exertion or while supine, should undergo urgent cardiac evaluation 50, 52

Diagnostic Testing

• The European Society of Cardiology recommends targeted diagnostic testing, including continuous cardiac telemetry monitoring, transthoracic echocardiography, and exercise stress testing, based on the initial evaluation findings 50, 52
• The American Heart Association suggests that prolonged ECG monitoring, including Holter and external loop recorder monitoring, may be useful in patients with recurrent unexplained syncope 53

Management

• The European Society of Cardiology recommends reappraising patients with unexplained syncope after initial evaluation and targeted testing, including obtaining additional history details and re-examining the patient for subtle findings 50
• The American College of Cardiology suggests that implantable loop recorder monitoring may be useful in patients with recurrent unexplained syncope and high clinical suspicion for arrhythmic cause 53

Evaluation and Management of Syncope

Initial Evaluation and Risk Stratification

• The European Society of Cardiology recommends that every patient presenting with syncope requires three mandatory components: detailed history, physical examination with orthostatic blood pressure measurements, and a 12-lead ECG—this triad alone establishes the diagnosis in 23-50% of cases 54
• Position during syncope (supine suggests cardiac cause; standing suggests reflex or orthostatic) is a critical historical feature to document 54
• Activity (exertional syncope is high-risk and mandates cardiac evaluation) is an important factor to consider in the initial evaluation 54
• Triggers (warm crowded places, prolonged standing, emotional stress suggest vasovagal; urination, defecation, cough suggest situational syncope) can help guide the diagnosis 54
• The presence of warning symptoms (nausea, diaphoresis, blurred vision, dizziness favor vasovagal syncope) can aid in distinguishing between different types of syncope 54
• Palpitations before syncope strongly suggest an arrhythmic cause 54
• Orthostatic vital signs in lying, sitting, and standing positions (orthostatic hypotension defined as systolic BP drop ≥20 mmHg or to <90 mmHg) are essential in the physical examination 54
• Carotid sinus massage in patients >40 years (positive if asystole >3 seconds or systolic BP drop >50 mmHg) can help diagnose carotid sinus syncope 54
• QT prolongation (long QT syndrome) is an important finding on the 12-lead ECG 54
• Conduction abnormalities (bundle branch blocks, bifascicular block) can be identified on the 12-lead ECG 54
• Signs of ischemia or prior MI can be detected on the 12-lead ECG 54
• Age >60-65 years is a high-risk feature requiring hospital admission 54
• Exercise stress testing is mandatory for syncope during or immediately after exertion 54
• Tilt-table testing can confirm vasovagal syncope in young patients without heart disease when history is suggestive but not diagnostic 54
• Echocardiography is immediately ordered for evaluation of valvular disease, cardiomyopathy, or ventricular function when structural heart disease is suspected 54
• Continuous cardiac telemetry monitoring is initiated immediately for patients with abnormal ECG, palpitations before syncope, or high-risk features when arrhythmic syncope is suspected 54

Evaluation and Management of Syncope with Preceding Shortness of Breath

Immediate Initial Assessment

• The American Heart Association recommends that patients with syncope and shortness of breath undergo immediate hospital admission for cardiac evaluation, given the high-risk presentation that carries 18-33% one-year mortality if left undiagnosed 55
• A complete cardiovascular examination, including orthostatic vital signs and assessment for murmurs, gallops, and rubs, is crucial in patients with syncope, as it may indicate structural heart disease 56
• Associated chest pain requires evaluation for acute coronary syndrome, which is a high-risk feature for cardiac syncope 55

High-Risk Features Requiring Hospital Admission

• Shortness of breath with syncope suggests a cardiac etiology with potential structural disease or arrhythmia, and is an independent predictor of increased mortality 55
• The American College of Cardiology recommends hospital admission for patients with syncope and high-risk features, such as shortness of breath, as they may have a cardiac cause with significant mortality 55

Risk Stratification for Cardiac Syncope

• One-year mortality for cardiac syncope is 18-33% versus 3-4% for noncardiac causes, emphasizing the need for aggressive evaluation in patients with high-risk features 55
• Shortness of breath preceding syncope may be due to arrhythmia, structural heart disease, pulmonary embolism, or severe valvular disease, all of which require prompt evaluation and management 57

Management Algorithm After Initial Evaluation

• If a cardiac cause is identified, management may involve pacemaker implantation, ICD placement, or ablation for arrhythmic syncope, or treatment of underlying structural heart disease 56
• The American Heart Association recommends continuous cardiac telemetry monitoring and transthoracic echocardiography in patients with suspected cardiac syncope, particularly those with dyspnea 56

Inpatient Syncope Evaluation and Management

Patient Selection for Hospital Admission

• Hospital admission is recommended for patients with serious medical conditions, including arrhythmic causes requiring device consideration, structural cardiac disease, or noncardiac conditions like severe anemia or pulmonary embolism, as stated by the American College of Cardiology 58, 59
• The presence of ≥1 serious medical condition is the key determinant for continued hospital-based management, rather than individual risk scores, according to the American College of Cardiology 58, 60

Risk Stratification and Diagnostic Approach

• High-risk features requiring aggressive inpatient evaluation include age >60-65 years, known structural heart disease or heart failure, syncope during exertion or supine position, brief/absent prodrome, abnormal cardiac examination or ECG, and family history of sudden cardiac death, as recommended by the American College of Cardiology and the American Heart Association 58, 59

Treatment and Management

• Arrhythmic causes may require pacemaker/ICD placement or revision, medication modification, or catheter ablation, as stated by the American College of Cardiology and the American Heart Association 58, 59
• Structural cardiac causes require treatment of underlying condition, such as medication management and consideration of surgical intervention for critical aortic stenosis, according to the American College of Cardiology and the American Heart Association 58, 59
• Noncardiac serious conditions require management of underlying problem, such as transfusion for severe anemia from gastrointestinal bleed, as recommended by the American College of Cardiology and the American Heart Association 58, 59

Disposition and Follow-up

• Structured ED observation protocols can be effective alternatives to full inpatient admission for intermediate-risk patients, consisting of time-limited observation and expedited access to cardiac testing/consultation, as stated by the American Heart Association 59
• Specialized syncope evaluation units may lead to reduced health service use and increased diagnostic rates, though their role in North American settings requires further validation, according to the American College of Cardiology 58, 60

Evaluation and Management of Syncopal Episodes

Initial Assessment and Risk Stratification

• A complete cardiovascular examination, including assessment for murmurs, gallops, rubs, and signs of heart failure, is essential in the initial evaluation of patients with syncope, as recommended by the American College of Emergency Physicians 61
• An abnormal ECG is a multivariate predictor for arrhythmia or death within 1 year, and should be assessed for QT prolongation, conduction abnormalities, and evidence of myocardial infarction or ischemia, according to the American Heart Association 61

Risk Stratification for Disposition

• The American College of Emergency Physicians identifies four multivariate predictors of adverse outcome: history of ventricular arrhythmias, abnormal ECG in the ED, age older than 45 years, and history of congestive heart failure, with patients having 3-4 risk factors having a 57.6-80.4% risk of 1-year mortality or significant arrhythmia 61, 62
• One-year mortality for cardiac syncope is 18-33% versus 3-4% for noncardiac causes, and cardiac syncope is an independent predictor of mortality even after adjusting for baseline comorbidities, as stated by the American College of Cardiology 61, 62

Directed Testing Based on Initial Evaluation

• Continuous cardiac telemetry monitoring should be initiated immediately for patients with abnormal ECG, palpitations before syncope, or high-risk features, and monitoring longer than 24 hours is not likely to increase yield of significant arrhythmias for most patients, according to the American College of Emergency Physicians 61, 62
• Blood tests, such as hemoglobin/hematocrit and pregnancy test, should only be ordered based on specific clinical suspicion, as routine use is not recommended by the American College of Emergency Physicians 61, 62

Ear Ringing and Near Syncope: Clinical Implications

Diagnostic Considerations

• The European Society of Cardiology and American College of Cardiology syncope guidelines do not list tinnitus among the prodromal symptoms to assess during history-taking for syncope evaluation 63, 64
• Absence of warning symptoms is actually a high-risk feature suggesting cardiac syncope, particularly arrhythmic causes [@17@]
• Nausea, diaphoresis, blurred vision, and dizziness are the characteristic prodromal features that favor vasovagal syncope [@15@]

Clinical Evaluation

• If a patient reports ear ringing with near syncope, focus your evaluation on the established high-risk features: abnormal ECG, known structural heart disease, exertional symptoms, absence of typical prodromal symptoms, and palpitations [@17@]
• Obtain orthostatic vital signs to assess for orthostatic hypotension, which causes presyncope with various atypical symptoms including vision changes [@15@]

Syncopal Episode Workup and Management

Initial Assessment

• The European Society of Cardiology recommends a detailed history, physical examination, and 12-lead ECG as the initial assessment for syncopal episodes, which can establish the diagnosis in 23-50% of cases 65, 66, 67
• The American College of Cardiology suggests that exertional syncope is high-risk and mandates cardiac evaluation 66
• The European Heart Journal states that palpitations before syncope strongly suggest an arrhythmic cause 65, 67

Risk Stratification

• The American College of Cardiology recommends hospital admission for patients with high-risk features, including age >60-65 years, known structural heart disease or heart failure, syncope during exertion, brief or absent prodrome, abnormal cardiac examination, abnormal ECG, and family history of sudden cardiac death 66
• The European Heart Journal suggests that one-year mortality for cardiac syncope is 18-33% versus 3-4% for noncardiac causes 65, 67

Directed Testing

• The American College of Cardiology recommends echocardiography for patients with abnormal cardiac examination, abnormal ECG suggesting structural disease, syncope during exertion, and known or suspected structural heart disease 66
• The European Heart Journal suggests that tilt-table testing may be considered for recurrent unexplained syncope in young patients without heart disease 65, 67

Management

• The American College of Cardiology recommends treatment of underlying conditions for cardiac syncope, including arrhythmic causes and structural heart disease 66
• The European Heart Journal states that beta-blockers are not effective for vasovagal syncope 65, 67

Common Pitfalls to Avoid

• The American College of Cardiology advises against ordering comprehensive laboratory panels without specific clinical indication 66
• The European Heart Journal suggests that brain imaging (CT/MRI) should only be ordered if focal neurological findings are present 65, 67